Viome
Data driven. Evidence based. The future of health is here.
- Headquarters
- Seattle, Washington
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2C
- Website
- viome.com
- Total Funding
- $218.5M
- Last Round
- $25.0M Series DJan 2024
- Rounds
- 5
About
Viome is a direct-to-consumer health company that uses AI-powered RNA sequencing to analyze the gut microbiome and deliver personalized nutrition recommendations, supplement formulas, and probiotics. Its at-home tests cover gut, oral, and full-body health, translating complex biological data into actionable food and supplement guidance. The platform has analyzed over 600,000 samples.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe
Mehiläinen is a leading Finnish private healthcare company providing medical, health, and special...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Biopharmaceutical services company